XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   3,944,000    
Beginning balance at Dec. 31, 2022 $ (2,066) $ 0 $ 83,804 $ (85,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (17,983)     (17,983)
Issuance of warrants in connection with Credit Agreement amendment 4,060   4,060  
Vesting of restricted stock units (in shares)   93,000    
Repurchase of restricted stock for payroll tax withholding (in shares)   (16,000)    
Repurchases of restricted stock for payroll tax withholding (247)   (247)  
Stock-based compensation expense 4,303   4,303  
Ending balance (in shares) at Jun. 30, 2023   4,021,000    
Ending balance at Jun. 30, 2023 (11,933) $ 0 91,920 (103,853)
Beginning balance (in shares) at Mar. 31, 2023   3,982,000    
Beginning balance at Mar. 31, 2023 (6,624) $ 0 89,791 (96,415)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (7,438)     (7,438)
Vesting of restricted stock units (in shares)   44,000    
Repurchase of restricted stock for payroll tax withholding (in shares)   (5,000)    
Repurchases of restricted stock for payroll tax withholding (84)   (84)  
Stock-based compensation expense 2,213   2,213  
Ending balance (in shares) at Jun. 30, 2023   4,021,000    
Ending balance at Jun. 30, 2023 $ (11,933) $ 0 91,920 (103,853)
Beginning balance (in shares) at Dec. 31, 2023 4,072,713 4,073,000    
Beginning balance at Dec. 31, 2023 $ (27,992) $ 0 94,544 (122,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (7,458)     (7,458)
Stock options exercised (in shares)   4,000    
Stock options exercised 18   18  
Vesting of restricted stock units (in shares)   122,000    
Repurchase of restricted stock for payroll tax withholding (in shares)   (30,000)    
Repurchases of restricted stock for payroll tax withholding (457)   (457)  
Stock-based compensation expense $ 2,943   2,943  
Ending balance (in shares) at Jun. 30, 2024 4,168,919 4,169,000    
Ending balance at Jun. 30, 2024 $ (32,946) $ 0 97,048 (129,994)
Beginning balance (in shares) at Mar. 31, 2024   4,106,000    
Beginning balance at Mar. 31, 2024 (27,483) $ 0 95,623 (123,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (6,888)     (6,888)
Stock options exercised (in shares)   4,000    
Stock options exercised 18   18  
Vesting of restricted stock units (in shares)   67,000    
Repurchase of restricted stock for payroll tax withholding (in shares)   (8,000)    
Repurchases of restricted stock for payroll tax withholding (145)   (145)  
Stock-based compensation expense $ 1,552   1,552  
Ending balance (in shares) at Jun. 30, 2024 4,168,919 4,169,000    
Ending balance at Jun. 30, 2024 $ (32,946) $ 0 $ 97,048 $ (129,994)